These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2463117

  • 1. Four fluorescence polarization immunoassays for therapeutic drug monitoring evaluated.
    Haver VM, Audino N, Burris S, Nelson M.
    Clin Chem; 1989 Jan; 35(1):138-40. PubMed ID: 2463117
    [Abstract] [Full Text] [Related]

  • 2. Fluorescence polarization immunoassay of quinidine, procainamide, and N-acetylprocainamide using Cobas-FP reagents.
    Lam YW, Watkins CE.
    Clin Pharm; 1993 Jan; 12(1):49-52. PubMed ID: 7679064
    [No Abstract] [Full Text] [Related]

  • 3. Simultaneous quantitation of quinidine, procainamide, and N-acetylprocainamide in serum by gas-liquid chromatography with a nitrogen-phosphorus selective detector.
    Kessler KM, Ho-Tung P, Steele B, Silver J, Pickoff A, Narayanan S, Myerburg RJ.
    Clin Chem; 1982 May; 28(5):1187-90. PubMed ID: 6176367
    [Abstract] [Full Text] [Related]

  • 4. Performance of a fluorescence polarization immunoassay system evaluated by therapeutic monitoring of four drugs.
    Zaninotto M, Secchiero S, Paleari CD, Burlina A.
    Ther Drug Monit; 1992 Aug; 14(4):301-5. PubMed ID: 1519304
    [Abstract] [Full Text] [Related]

  • 5. Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method.
    MacKichan JJ, Coyle JD, Shields BJ, Boudoulas H, Lima JJ.
    Clin Chem; 1984 May; 30(5):768-73. PubMed ID: 6201304
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of the TDX fluorescence polarization immunoassays for procainamide and n-acetylprocainamide.
    Sonsalla PK, Bridges RR, Jennison TA, Smith CM.
    J Anal Toxicol; 1985 May; 9(4):152-5. PubMed ID: 2412001
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of the EMIT procainamide and N-acetylprocainamide assay.
    Walberg CB, Wan SH.
    Ther Drug Monit; 1979 May; 1(1):47-56. PubMed ID: 95422
    [Abstract] [Full Text] [Related]

  • 8. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
    Henry PR, Dhruv RA.
    Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
    [Abstract] [Full Text] [Related]

  • 9. Multicenter evaluation of the Abbott AxSYM procainamide and N-acetylprocainamide assays: comparison with Abbott TDx/TDxFLx, Syva EMIT 2000, DuPont ACA, and HPLC methods.
    Azzazy HM, Chou PP, Poklis A, Shock G, Christenson RH.
    Clin Biochem; 1998 Feb; 31(1):55-8. PubMed ID: 9559226
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA, Coyle JD.
    Pharmacotherapy; 1992 Feb; 12(1):40-4. PubMed ID: 1372425
    [Abstract] [Full Text] [Related]

  • 11. Enzyme immunoassay, liquid chromatography, and spectrofluorometry compared for the determination of procainamide and N-acetylprocainamide in serum.
    Pape BE.
    J Anal Toxicol; 1982 Feb; 6(1):44-8. PubMed ID: 6176781
    [Abstract] [Full Text] [Related]

  • 12. Improved liquid chromatographic determination of procainamide and N-acetylprocainamide in serum.
    Patel CP.
    Ther Drug Monit; 1983 Jun; 5(2):235-8. PubMed ID: 6192559
    [Abstract] [Full Text] [Related]

  • 13. Comparison of three immunoassays for the determination of N-acetylprocainamide. Determination of false elevations by a polyclonal antibody-based method.
    Laurino JP, McKay J, Fischberg E, Schwenzer K, Kaufman R.
    Ther Drug Monit; 1994 Jun; 16(3):312-5. PubMed ID: 7521980
    [Abstract] [Full Text] [Related]

  • 14. Antiarrhythmic drug monitoring.
    Howanitz JH, Howanitz PJ.
    Clin Lab Med; 1981 Sep; 1(3):501-22. PubMed ID: 6179688
    [No Abstract] [Full Text] [Related]

  • 15. High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts.
    Wesley JF, Lasky FD.
    Clin Biochem; 1981 Jun; 14(3):113-8. PubMed ID: 6170476
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
    Oeltgen PR, Shank WA, Blouin RA, Clark T.
    Ther Drug Monit; 1984 Jun; 6(3):360-7. PubMed ID: 6390799
    [Abstract] [Full Text] [Related]

  • 17. Comparison of fluorescence polarization immunoassay with liquid chromatography for quantification of procainamide and N-acetylprocainamide in urine.
    Tisdale JE, Padhi ID, Ware JA, Svensson CK.
    Ther Drug Monit; 1996 Dec; 18(6):693-7. PubMed ID: 8946667
    [Abstract] [Full Text] [Related]

  • 18. Assay of serum procainamide and N-acetylprocainamide: a comparison of emit and reverse-phase high-performance liquid chromatography.
    Griffiths WC, Dextraze P, Hayes M, Mitchell J, Diamond I.
    Clin Toxicol; 1980 Mar; 16(1):51-4. PubMed ID: 6156051
    [No Abstract] [Full Text] [Related]

  • 19. High performance liquid chromatography of procainamide and N-acetylprocainamide in human blood plasma.
    Raphanaud D, Borensztejn M, Dupeyron JP, Guyon F.
    Ther Drug Monit; 1986 Mar; 8(3):365-7. PubMed ID: 2428144
    [Abstract] [Full Text] [Related]

  • 20. Comparison of high-performance liquid chromatography with an enzyme multiplied immunoassay technique for the analysis of serum procainamide and N-acetylprocainamide.
    Gallaher C, Henderson GL, Low RI, Amsterdam EA, Mason DT.
    J Chromatogr; 1980 Mar 14; 181(3-4):490-6. PubMed ID: 6156181
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.